Tribbia, Christina M.

Glenn Krinsky's practice focuses on the representation of academic medical centers and other health care providers.  Glenn also represents established and emerging biotechnology industry clients.

Before joining Jones Day, Glenn served as chief legal officer and executive vice president of City of Hope National Medical Center and Beckman Research Institute in Duarte, California, one of the nation's most renowned biomedical research and clinical cancer treatment facilities.  During his tenure at City of Hope, Glenn was responsible for all health care law issues, as well as litigation, corporate governance issues, labor and employment, patent and trademark portfolio management, bond financings, nonprofit tax and other section 501(c)(3) issues, real estate transactions, crisis management, and federal lobbying activities.  Glenn supervised City of Hope's 2002 trial against biotechnology industry leader Genentech, which resulted in a jury verdict of $500 million, and that verdict was unanimously upheld by the California Court of Appeal in October 2004.  In his capacity as chief legal officer, Glenn also successfully defended City of Hope in a comprehensive investigation conducted by the California Attorney General's Office, which resulted in a "no-action" letter. In addition, Glenn successfully negotiated with major media organizations, including the CBS News program "60 Minutes" and the Los Angeles Times, regarding coverage of the issues presented in the Attorney General's investigation.

Prior to City of Hope, Glenn spent 12 years in private practice in Los Angeles and Washington, D.C., where he focused his efforts on the representation of major charities and other tax-exempt organizations. 

Glenn also has been an adjunct professor at the University of Southern California and Loyola University School of Law.